Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products > Novel inhibitors

Novel inhibitors

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC2135 Flufenacet
Herbicide, inhibiting very-long-chain fatty acid elongase (VLCFAE) synthesis
More description
DCC2134 flu-dnb
Novel photolabile NO donor
More description
DCC2133 Flubendiamide
The first phthalic acid diamide insecticide, impairs neuronal calcium signalling in the honey bees antennae
More description
DCC2132 fluacrypyrim
Novel STAT3 activation inhibitor, induces cell cycle arrest and apoptosis in cancer cells harboring constitutively-active STAT3
More description
DCC2131 Flt3-in-50
Novel selective and efficacious inhibitor of FLT3 mutations
More description
DCC2130 Flt3 Inhibitor Iv
Novel potent ATP-competitive inhibitor of Flt3
More description
DCC2129 Flt3 Inhibitor 17
Novel FLT3 inhibitor, displaying potent inhibitory activity against the FLT3-ITD mutant (IC 50 = 0.8 nM) and good selectivity over c-KIT kinase (over 500-fold), selectively inhibiting the proliferation of FLT3-ITD-positive AML cell lines MV4-11 (IC 50 = 2
More description
DCC2128 Flortanidazole
Tumour hypoxia probe
More description
DCC2127 flll62
Inhibitor of STAT3 phosphorylation and apoptotic promoter of human renal cell carcinoma and melanoma cell lines
More description
DCC2126 Flll12
Curcumin analogue, exhibiting enhanced growth-suppressive activity and inhibiting AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells
More description
DCC2125 Flll11
Curcumin analogue, exhibiting enhanced growth-suppressive activity and inhibiting AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells
More description
DCC2124 fli-28
Novel inhibitor of general secretion in early stage; FLI-06 analogue twice as active as FLI-06
More description
DCC2123 Flg249
Novel, potent, orally active, and nonsteroidal farnesoid X receptor (FXR) antagonist with propensity for accumulation and responsiveness in ileum
More description
DCC2122 Flemingin A
Natural anticancer and antioxidant
More description
DCC2121 Flaviviruses-inhibitor-i
Specific inhibitor of several viruses belonging to the family of flaviviridae
More description
DCC2120 Fkbp12-in-q2
Novel Inhibitor of FKBP12
More description
DCC2119 Fk-3657
Novel non-peptide bradykinin (BK)-B2 receptor antagonist
More description
DCC2118 Fk1012-a
Highly potent membrane-permeable ligand of the immunophilin FKBP12, creating a new composite FKBP12-FK506 surface and inactivating calcineurin, a Ca calmodulin-dependent protein phosphatase
More description
DCC2117 Fitc-sulfono-γ-aa Peptide
Fluorescent protein-protein interaction (PPI) inhibitor
More description
DCC2116 Fischerin
Natural potent cytotoxic agent
More description
DCC2115 Finafloxacin Hydrochloride
Antibacterial agent, expressing enhanced activity at acidic pH
More description
DCC2114 Fibronectin Cs1 Peptide
Cell-adhesive octapeptide as the authentic sequence within intact fibronectin, mediating OSCC cell spreading, migration, and invasion, regulating IL-17A levels and mechanical allodynia after peripheral nerve injury
More description
DCC2113 Fibronectin Adhesion-promoting Peptide
Potent macrophage activator, enhancing interleukin 12-dependent interferon gamma production by lipopolysaccharide-stimulated mouse splenocytes, exerting an antiviral action against HSV-1 with the independent pathways of IFN-alpha
More description
DCC2112 Fibroblast Growth Factor (1-10)
Fibroblast growth factor fragment
More description
DCC2111 Fhu-779
Novel light-regulated diltiazem derivative, photoswitching LTCC in pancreatic β cells, cardiomyocytes and mouse hearts
More description
DCC2110 Fh535-n
Novel inhibitor of the Wnt/β-catenin transcriptional activity, demonstrating significant increased rate of apoptosis in Huh7 and PLC/PRF
More description
DCC2109 Fh1024 Tfa Salt
Novel regulator of transcription factor PU.1-DNA binding interactions, acting as a weak agonist that recruits PU.1 to DNA
More description
DCC2108 Fgfr-in-21
Novel potentl and selective covalent FGFR inhibitor, inhibiting proliferation of FGFR-amplified cancer cell lines with low nM IC50 values
More description
DCC2107 Fgfr4 Inhibitor F-30
Novel potent and selective FGFR4 inhibitor, covalently binding to FGFR4 protein
More description
DCC2106 Fgfr4 Inhibitor 7v
Novel highly selective covalent inhibitor of wild-type and gatekeeper mutant FGFR4, exhibiting excellent potency against FGFR4, FGFR4V550L, and FGFR4V550M with nanomolar activity in both the biochemical and cellular assays while sparing FGFR1/2/3
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X